Old Web
English
Sign In
Acemap
>
Paper
>
P593 Ustekinumab for the treatment of perianal Crohn’s disease. A real-world experience in a Spanish hospital
P593 Ustekinumab for the treatment of perianal Crohn’s disease. A real-world experience in a Spanish hospital
2021
M Algara San Nicolas
A Masedo-González
G J Gómez-Gómez
C. Yela San Bernardino
B. Casis Herce
M. P. Martínez-Montiel
Keywords:
Internal medicine
Medicine
Adverse effect
Vedolizumab
Bowel resection
Gastroenterology
Irritable bowel syndrome
Sarcoma
Inflammatory bowel disease
Ustekinumab
Ciliary Motility Disorders
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]